These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8359515)

  • 1. Apolipoproteins E and C-III have opposing roles in the clearance of lipoprotein remnants in transgenic mice.
    de Silva HV; Lauer SJ; Mahley RW; Weisgraber KH; Taylor JM
    Biochem Soc Trans; 1993 May; 21(2):483-7. PubMed ID: 8359515
    [No Abstract]   [Full Text] [Related]  

  • 2. Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice.
    Jong MC; Havekes LM
    Int J Tissue React; 2000; 22(2-3):59-66. PubMed ID: 10937355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3.
    Jong MC; Hofker MH; Havekes LM
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):472-84. PubMed ID: 10073946
    [No Abstract]   [Full Text] [Related]  

  • 4. The amino-terminal 1-185 domain of apoE promotes the clearance of lipoprotein remnants in vivo. The carboxy-terminal domain is required for induction of hyperlipidemia in normal and apoE-deficient mice.
    Kypreos KE; Morani P; van Dijk KW; Havekes LM; Zannis VI
    Biochemistry; 2001 May; 40(20):6027-35. PubMed ID: 11352738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The metabolism and function of apolipoprotein C-III].
    Ebara T
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():125-30. PubMed ID: 11351559
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B.
    Shimano H; Yamada N; Katsuki M; Yamamoto K; Gotoda T; Harada K; Shimada M; Yazaki Y
    J Clin Invest; 1992 Nov; 90(5):2084-91. PubMed ID: 1430232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mouse models of lipoprotein metabolism and atherosclerosis.
    Breslow JL
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8314-8. PubMed ID: 8378301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular variants of the lipoproteins.
    Galton DJ; Stocks J; Rees A
    Clin Sci (Lond); 1983 Jun; 64(6):559-63. PubMed ID: 6404583
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycosylation of lipoproteins: chemistry and biological implications.
    Flückiger R
    Monogr Atheroscler; 1985; 13():53-62. PubMed ID: 3911059
    [No Abstract]   [Full Text] [Related]  

  • 10. [Separation of lipoproteins as a function of their apolipoprotein composition. Clinical applications].
    Fruchart JC
    Ann Biol Clin (Paris); 1986; 44(2):116-21. PubMed ID: 3092704
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl.
    Shachter NS; Ebara T; Ramakrishnan R; Steiner G; Breslow JL; Ginsberg HN; Smith JD
    J Clin Invest; 1996 Aug; 98(3):846-55. PubMed ID: 8698877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.
    Ebara T; Ramakrishnan R; Steiner G; Shachter NS
    J Clin Invest; 1997 Jun; 99(11):2672-81. PubMed ID: 9169497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoproteins B, C-III and E in two major subpopulations of low-density lipoproteins.
    Lee DM; Alaupovic P
    Biochim Biophys Acta; 1986 Nov; 879(2):126-33. PubMed ID: 3768392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase.
    Jeong Ts; Schissel SL; Tabas I; Pownall HJ; Tall AR; Jiang X
    J Clin Invest; 1998 Feb; 101(4):905-12. PubMed ID: 9466986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very low density lipoprotein subfraction apolipoprotein composition.
    Fisher RM; Coppack SW; Kottke BA; Miles JM
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):231S. PubMed ID: 8224388
    [No Abstract]   [Full Text] [Related]  

  • 16. Over expression of human apoCIII gene leads to hypertriglyceridemia in transgenic mice.
    Indian J Exp Biol; 1991 Jan; 29(1):99. PubMed ID: 1864630
    [No Abstract]   [Full Text] [Related]  

  • 17. Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in vivo.
    Heeren J; Niemeier A; Merkel M; Beisiegel U
    J Mol Med (Berl); 2002 Sep; 80(9):576-84. PubMed ID: 12226739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of apolipoprotein CIII in triglyceride-rich lipoprotein metabolism.
    Fredenrich A
    Diabetes Metab; 1998 Dec; 24(6):490-5. PubMed ID: 9932215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice.
    Baroukh N; Bauge E; Akiyama J; Chang J; Afzal V; Fruchart JC; Rubin EM; Fruchart-Najib J; Pennacchio LA
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1297-302. PubMed ID: 15117734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein analysis in transgenic mice expressing human apolipoprotein (apo) A-I and apo C III: use of micromethods in analysis of lipoprotein system in mice.
    Ito Y
    Hokkaido Igaku Zasshi; 1994 Mar; 69(2):312-26. PubMed ID: 8157256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.